よむ、つかう、まなぶ。
11【参考資料１－６】9価HPVワクチンファクトシート (42 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_29181.html |
| 出典情報 | 厚生科学審議会予防接種・ワクチン分科会（第41回 11／18）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
1624
https://www.ncbi.nlm.nih.gov/pubmed/28541571
1660
to 2017. BMC Infect Dis 20(1): 297.
1625
29. 国⽴がん研究センター がん情報サービス.(2020). 全国がん罹患データ（2016 年-2017
1661
42. Orumaa, M., et al. (2020). The impact of HPV multi-cohort vaccination: Real-world
1626
年) cancer_incidenceNCR(2016-2017).xls.
1662
evidence of faster control of HPV-related morbidity. Vaccine 38(6): 1345-1351.
1627
https://ganjoho.jp/reg_stat/statistics/dl/index.html
1663
43. 国⽴がん研究センター「がん情報サービス」
．全国がん死亡データ（1958 年-2018 年）
1628
30. 国⽴がん研究センター がん対策情報センター.(2018).「がん登録・統計」⼩児・AYA
1664
cancer_mortality(1958-2018).xls．https://ganjoho.jp/reg_stat/statistics/dl/index.html
1629
世代のがんの罹患率．https://ganjoho.jp/reg_stat/statistics/stat/child_aya.html
1665
44. WHO (2019). Cancer Mortality Database
1630
31. Jung, K. W., et al. (2019). Cancer Statistics in Korea: Incidence, Mortality, Survival, and
1666
https://www-dep.iarc.fr/WHOdb/WHOdb.htm
1631
Prevalence in 2016. Cancer Res Treat 51(2): 417-430.
1667
45.
1632
https://www.ncbi.nlm.nih.gov/pubmed/30913865
1668
Screening Program in Korea: A Retrospective Observational Study. Asian Nurs Res (Korean
Soc Nurs Sci) 12(1): 9-16. https://www.ncbi.nlm.nih.gov/pubmed/29463482
Lee, J. H., et al. (2018). Contributions and Limitations of National Cervical Cancer
1633
32. Cancer Incidence in Five Continents Time Trends, I., WHO (2018). NPCR: National
1669
1634
Program of Cancer Registries. https://ci5.iarc.fr/CI5plus/Default.aspx
1670
46. Smith, M. and K. Canfell (2016). Impact of the Australian National Cervical Screening
1635
33. 国⽴がん研究センター がん情報サービス. (2020).全国推計値：がん罹患データ（1975
1671
Program in women of different ages. Med J Aust 205(8): 359-364.
1636
年-2015 年）cancer_incidence(1975-2015).xls
1672
https://www.ncbi.nlm.nih.gov/pubmed/27736623
1637
https://ganjoho.jp/reg_stat/statistics/dl/index.html
1673
47. 公益財団法⼈ がん研究振興財団. (2020)がん統計'19.
1638
34.
Saito, T., et al. (2017). Annual Report of the Committee on Gynecologic Oncology,
1674
https://www.fpcr.or.jp/data_files/view/41/mode:inline
1639
Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment
1675
48. Van Doorslaer, K., et al. (2017). The Papillomavirus Episteme: a major update to the
1640
Annual Report for 2009. J Obstet Gynaecol Res 43(11): 1667-1677.
1676
papillomavirus
1641
https://www.ncbi.nlm.nih.gov/pubmed/28892220
1677
https://www.ncbi.nlm.nih.gov/pubmed/28053164
1642
35. 厚⽣労働省 国⽴感染症研究所. (2020).感染症週報 2020 年第 42 週・50 週．通巻第 22
1678
49.
1643
巻第 42 号・50 号.
1679
cancer progression: a comprehensive review. Clin Sci (Lond) 131(17): 2201-2221.
sequence
database.
Nucleic
Acids
Res
45(D1):
D499-D506.
Graham, S. V. (2017). The human papillomavirus replication cycle, and its links to
1644
https://www.niid.go.jp/niid/images/idsc/idwr/IDWR2020/idwr2020-42.pdf
1680
https://www.ncbi.nlm.nih.gov/pubmed/28798073
1645
https://www.niid.go.jp/niid/images/idsc/idwr/IDWR2020/idwr2020-50.pdf
1681
50. Cobos, C., et al. (2014). The role of human papilloma virus (HPV) infection in non-
1646
36. Kawado, M., et al. (2020). Estimating nationwide cases of sexually transmitted diseases
1682
anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol 33(5): 383-
1647
in 2015 from sentinel surveillance data in Japan. BMC Infect Dis 20(1): 77.
1683
401. https://www.ncbi.nlm.nih.gov/pubmed/24811210
1648
37.
Drolet, M., et al. (2019). Population-level impact and herd effects following the
1684
51. Brianti, P., et al. (2017). Review of HPV-related diseases and cancers. New Microbiol
1649
introduction of human papillomavirus vaccination programmes: updated systematic review
1685
40(2): 80-85. https://www.ncbi.nlm.nih.gov/pubmed/28368072
1650
and meta-analysis. Lancet 394(10197): 497-509.
1686
52.
1651
38.
Shing, J. Z., et al. (2019). Trends in anogenital wart incidence among Tennessee
1687
States, 2012-2016. MMWR Morb Mortal Wkly Rep 68(33): 724-728
1652
Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.
1688
53.
1653
Papillomavirus Res 7: 141-149.
1689
cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep 61: 258-261.
1654
39. Stanley, M. (2014). HPV vaccination in boys and men. Hum Vaccin Immunother 10(7):
1690
https://www.ncbi.nlm.nih.gov/pubmed/22513527
1655
2109-2111.
1691
54. Clifford, G. M., et al. (2005). Human papillomavirus genotype distribution in low-grade
1656
40. Al-Awadhi, R., et al. (2019). Association of HPV genotypes with external anogenital
1692
cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol
1657
warts: a cross sectional study. BMC Infect Dis 19(1): 375.
1693
Biomarkers Prev 14(5): 1157-1164. https://www.ncbi.nlm.nih.gov/pubmed/15894666
1658
41. Reuschenbach, M., et al. (2020). Burden of HPV related anogenital diseases in young
1694
55. X. Castellsague, S. d. S., T. Aguado, K.S. Louie, L. Bruni, J. Munoz, M. Diaz, K. Irwin,
1659
women in Germany - an analysis of German statutory health insurance claims data from 2012
1695
M. Gacic, O. Beauvais, G. Albero, E. Ferrer, S. Byrne, F.X. Bosch (2007). SECTION I.
83
Senkomago, V., et al. (2019). Human Papillomavirus-Attributable Cancers - United
Centers for Disease, C. and Prevention (2012). Human papillomavirus-associated
84
https://www.ncbi.nlm.nih.gov/pubmed/28541571
1660
to 2017. BMC Infect Dis 20(1): 297.
1625
29. 国⽴がん研究センター がん情報サービス.(2020). 全国がん罹患データ（2016 年-2017
1661
42. Orumaa, M., et al. (2020). The impact of HPV multi-cohort vaccination: Real-world
1626
年) cancer_incidenceNCR(2016-2017).xls.
1662
evidence of faster control of HPV-related morbidity. Vaccine 38(6): 1345-1351.
1627
https://ganjoho.jp/reg_stat/statistics/dl/index.html
1663
43. 国⽴がん研究センター「がん情報サービス」
．全国がん死亡データ（1958 年-2018 年）
1628
30. 国⽴がん研究センター がん対策情報センター.(2018).「がん登録・統計」⼩児・AYA
1664
cancer_mortality(1958-2018).xls．https://ganjoho.jp/reg_stat/statistics/dl/index.html
1629
世代のがんの罹患率．https://ganjoho.jp/reg_stat/statistics/stat/child_aya.html
1665
44. WHO (2019). Cancer Mortality Database
1630
31. Jung, K. W., et al. (2019). Cancer Statistics in Korea: Incidence, Mortality, Survival, and
1666
https://www-dep.iarc.fr/WHOdb/WHOdb.htm
1631
Prevalence in 2016. Cancer Res Treat 51(2): 417-430.
1667
45.
1632
https://www.ncbi.nlm.nih.gov/pubmed/30913865
1668
Screening Program in Korea: A Retrospective Observational Study. Asian Nurs Res (Korean
Soc Nurs Sci) 12(1): 9-16. https://www.ncbi.nlm.nih.gov/pubmed/29463482
Lee, J. H., et al. (2018). Contributions and Limitations of National Cervical Cancer
1633
32. Cancer Incidence in Five Continents Time Trends, I., WHO (2018). NPCR: National
1669
1634
Program of Cancer Registries. https://ci5.iarc.fr/CI5plus/Default.aspx
1670
46. Smith, M. and K. Canfell (2016). Impact of the Australian National Cervical Screening
1635
33. 国⽴がん研究センター がん情報サービス. (2020).全国推計値：がん罹患データ（1975
1671
Program in women of different ages. Med J Aust 205(8): 359-364.
1636
年-2015 年）cancer_incidence(1975-2015).xls
1672
https://www.ncbi.nlm.nih.gov/pubmed/27736623
1637
https://ganjoho.jp/reg_stat/statistics/dl/index.html
1673
47. 公益財団法⼈ がん研究振興財団. (2020)がん統計'19.
1638
34.
Saito, T., et al. (2017). Annual Report of the Committee on Gynecologic Oncology,
1674
https://www.fpcr.or.jp/data_files/view/41/mode:inline
1639
Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment
1675
48. Van Doorslaer, K., et al. (2017). The Papillomavirus Episteme: a major update to the
1640
Annual Report for 2009. J Obstet Gynaecol Res 43(11): 1667-1677.
1676
papillomavirus
1641
https://www.ncbi.nlm.nih.gov/pubmed/28892220
1677
https://www.ncbi.nlm.nih.gov/pubmed/28053164
1642
35. 厚⽣労働省 国⽴感染症研究所. (2020).感染症週報 2020 年第 42 週・50 週．通巻第 22
1678
49.
1643
巻第 42 号・50 号.
1679
cancer progression: a comprehensive review. Clin Sci (Lond) 131(17): 2201-2221.
sequence
database.
Nucleic
Acids
Res
45(D1):
D499-D506.
Graham, S. V. (2017). The human papillomavirus replication cycle, and its links to
1644
https://www.niid.go.jp/niid/images/idsc/idwr/IDWR2020/idwr2020-42.pdf
1680
https://www.ncbi.nlm.nih.gov/pubmed/28798073
1645
https://www.niid.go.jp/niid/images/idsc/idwr/IDWR2020/idwr2020-50.pdf
1681
50. Cobos, C., et al. (2014). The role of human papilloma virus (HPV) infection in non-
1646
36. Kawado, M., et al. (2020). Estimating nationwide cases of sexually transmitted diseases
1682
anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol 33(5): 383-
1647
in 2015 from sentinel surveillance data in Japan. BMC Infect Dis 20(1): 77.
1683
401. https://www.ncbi.nlm.nih.gov/pubmed/24811210
1648
37.
Drolet, M., et al. (2019). Population-level impact and herd effects following the
1684
51. Brianti, P., et al. (2017). Review of HPV-related diseases and cancers. New Microbiol
1649
introduction of human papillomavirus vaccination programmes: updated systematic review
1685
40(2): 80-85. https://www.ncbi.nlm.nih.gov/pubmed/28368072
1650
and meta-analysis. Lancet 394(10197): 497-509.
1686
52.
1651
38.
Shing, J. Z., et al. (2019). Trends in anogenital wart incidence among Tennessee
1687
States, 2012-2016. MMWR Morb Mortal Wkly Rep 68(33): 724-728
1652
Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.
1688
53.
1653
Papillomavirus Res 7: 141-149.
1689
cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep 61: 258-261.
1654
39. Stanley, M. (2014). HPV vaccination in boys and men. Hum Vaccin Immunother 10(7):
1690
https://www.ncbi.nlm.nih.gov/pubmed/22513527
1655
2109-2111.
1691
54. Clifford, G. M., et al. (2005). Human papillomavirus genotype distribution in low-grade
1656
40. Al-Awadhi, R., et al. (2019). Association of HPV genotypes with external anogenital
1692
cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol
1657
warts: a cross sectional study. BMC Infect Dis 19(1): 375.
1693
Biomarkers Prev 14(5): 1157-1164. https://www.ncbi.nlm.nih.gov/pubmed/15894666
1658
41. Reuschenbach, M., et al. (2020). Burden of HPV related anogenital diseases in young
1694
55. X. Castellsague, S. d. S., T. Aguado, K.S. Louie, L. Bruni, J. Munoz, M. Diaz, K. Irwin,
1659
women in Germany - an analysis of German statutory health insurance claims data from 2012
1695
M. Gacic, O. Beauvais, G. Albero, E. Ferrer, S. Byrne, F.X. Bosch (2007). SECTION I.
83
Senkomago, V., et al. (2019). Human Papillomavirus-Attributable Cancers - United
Centers for Disease, C. and Prevention (2012). Human papillomavirus-associated
84